Development and Validation of Analytical Method for Lower Dosage Form PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Development and Validation of Analytical Method for Lower Dosage Form PDF full book. Access full book title Development and Validation of Analytical Method for Lower Dosage Form by Bhavinkumar Vaishnani. Download full books in PDF and EPUB format.
Author: Bhavinkumar Vaishnani Publisher: LAP Lambert Academic Publishing ISBN: 9783844384284 Category : Languages : en Pages : 188
Book Description
To meet the emerging challenges of 21st century, the number of drugs introduced into the global pharmaceutical market is increasing every year. The focus on research and development of the drug molecule is to introduce either new entities or partial structural modification of the existing one to improve its potency and/or to reduce its adverse effect. Very often there is a time lag from the date of introduction of a drug into the market to the date of its inclusion in pharmacopoeias. This happens because of the possible uncertainties in the continuous and wider usage of these drugs, reports of new toxicities (resulting in their withdrawal from the market), development of patient resistance and introduction of better drugs by the competitors. Under these conditions, standard analytical procedures for these drugs may not be available in the pharmacopoeias. The analysis of high-potency, low-strength solid oral dosage forms poses a number of analytical challenges that can impact potency, purity and dissolution testing of the dosage form.
Author: Bhavinkumar Vaishnani Publisher: LAP Lambert Academic Publishing ISBN: 9783844384284 Category : Languages : en Pages : 188
Book Description
To meet the emerging challenges of 21st century, the number of drugs introduced into the global pharmaceutical market is increasing every year. The focus on research and development of the drug molecule is to introduce either new entities or partial structural modification of the existing one to improve its potency and/or to reduce its adverse effect. Very often there is a time lag from the date of introduction of a drug into the market to the date of its inclusion in pharmacopoeias. This happens because of the possible uncertainties in the continuous and wider usage of these drugs, reports of new toxicities (resulting in their withdrawal from the market), development of patient resistance and introduction of better drugs by the competitors. Under these conditions, standard analytical procedures for these drugs may not be available in the pharmacopoeias. The analysis of high-potency, low-strength solid oral dosage forms poses a number of analytical challenges that can impact potency, purity and dissolution testing of the dosage form.
Author: Michael E. Swartz Publisher: CRC Press ISBN: 1482229773 Category : Science Languages : en Pages : 95
Book Description
Describes analytical methods development, optimization and validation, and provides examples of successful methods development and validation in high-performance liquid chromatography (HPLC) areas. The text presents an overview of Food and Drug Administration (FDA)/International Conference on Harmonization (ICH) regulatory guidelines, compliance with validation requirements for regulatory agencies, and methods validation criteria stipulated by the US Pharmacopia, FDA and ICH.
Author: Michael E. Swartz Publisher: CRC Press ISBN: 142001448X Category : Medical Languages : en Pages : 218
Book Description
Written for practitioners in both the drug and biotechnology industries, this handbook carefully compiles the current regulatory requirements to correctly and properly validate a new or modified analytical method. The Handbook of Analytical Validation is designed to teach readers how to fully and correctly adapt new or modified analytical methods to meet regulatory requirements. The contents offer the latest regulatory requirements for submitting applications for new drugs or other applications, as regards analytical method validation. The chapters apply to both small molecules in the conventional pharmaceutical industry, as well the biotech industry.
Author: Satish Y. Gabhe Publisher: diplom.de ISBN: 3954898071 Category : Science Languages : en Pages : 108
Book Description
This book details: 1. Development and validation of a HPTLC-densitometric method for concurrent estimation of metformin hydrochloride, pioglitazone hydrochloride and gliclazide in combined dosage form. 2. Development and validation of a HPTLC method for simultaneous estimation of moxifloxacin hydrochloride and dexamethasone sodium phosphate in combined pharmaceutical dosage form. 3. Development and validation of a RP-HPLC method for simultaneous estimation of ciprofloxacin hydrochloride and dexamethasone in combined dosage form, which is a better alternative to existing ones. The developed analytical methods are simple, selective, accurate, robust, and precise with shorter analysis time for the analysis of drug/s in combined pharmaceutical dosage forms. All the developed HPTLC and HPLC methods have been validated as per ICH Q2 (R1) guideline. Developed analytical methods could boost analytical researchers to work more efficiently in the field of analytical method development and validation of Pharmaceutical dosage forms.
Author: Christopher M. Riley Publisher: Elsevier ISBN: 0080530354 Category : Science Languages : en Pages : 363
Book Description
The need to validate an analytical or bioanalytical method is encountered by analysts in the pharmaceutical industry on an almost daily basis, because adequately validated methods are a necessity for approvable regulatory filings. What constitutes a validated method, however, is subject to analyst interpretation because there is no universally accepted industry practice for assay validation. This book is intended to serve as a guide to the analyst in terms of the issues and parameters that must be considered in the development and validation of analytical methods. In addition to the critical issues surrounding method validation, this book also deals with other related factors such as method development, data acquisition, automation, cleaning validation and regulatory considerations. The book is divided into three parts. Part One, comprising two chapters, looks at some of the basic concepts of method validation. Chapter 1 discusses the general concept of validation and its role in the process of transferring methods from laboratory to laboratory. Chapter 2 looks at some of the critical parameters included in a validation program and the various statistical treatments given to these parameters. Part Two (Chapters 3, 4 and 5) of the book focuses on the regulatory perspective of analytical validation. Chapter 3 discusses in some detail how validation is treated by various regulatory agencies around the world, including the United States, Canada, the European Community, Australia and Japan. This chapter also discusses the International Conference on Harmonization (ICH) treatment of assay validation. Chapters 4 and 5 cover the issues and various perspectives of the recent United States vs. Barr Laboratories Inc. case involving the retesting of samples. Part Three (Chapters 6 - 12) covers the development and validation of various analytical components of the pharmaceutical product development process. This part of the book contains specific chapters dedicated to bulk drug substances and finished products, dissolution studies, robotics and automated workstations, biotechnology products, biological samples, analytical methods for cleaning procedures and computer systems and computer-aided validation. Each chapter goes into some detail describing the critical development and related validation considerations for each topic. This book is not intended to be a practical description of the analytical validation process, but more of a guide to the critical parameters and considerations that must be attended to in a pharmaceutical development program. Despite the existence of numerous guidelines including the recent attempts by the ICH to be implemented in 1998, the practical part of assay validation will always remain, to a certain extent, a matter of the personal preference of the analyst or company. Nevertheless, this book brings together the perspectives of several experts having extensive experience in different capacities in the pharmaceutical industry in an attempt to bring some consistency to analytical method development and validation.
Author: Joachim Ermer Publisher: John Wiley & Sons ISBN: 3527604472 Category : Science Languages : en Pages : 418
Book Description
Adopting a practical approach, the authors provide a detailed interpretation of the existing regulations (GMP, ICH), while also discussing the appropriate calculations, parameters and tests. The book thus allows readers to validate the analysis of pharmaceutical compounds while complying with both the regulations as well as the industry demands for robustness and cost effectiveness. Following an introduction to the basic parameters and tests in pharmaceutical validation, including specificity, linearity, range, precision, accuracy, detection and quantitation limits, the text focuses on a life-cycle approach to validation and the integration of validation into the whole analytical quality assurance system. The whole is rounded off with a look at future trends. With its first-hand knowledge of the industry as well as regulating bodies, this is an invaluable reference for analytical chemists, the pharmaceutical industry, pharmaceutists, QA officers, and public authorities.
Author: Deepali Chavan Publisher: LAP Lambert Academic Publishing ISBN: 9783838398471 Category : Languages : en Pages : 216
Book Description
A number of drugs are introduced in the market every year, also many new fixed dose combinations of already individually approved drugs are formulated with an aim to achieve better therapeutic efficacy. Pharmaceutical products formulated with more than one drug, typically referred to as combination products, are intended to meet previously unmet patients need by combining the therapeutic effects of two or more drugs in one product. These combination products can present daunting challenges to the analytical chemist responsible for the development and validation of analytical methods Many times few combinations do not have any official methods for simultaneous analysis of their "active pharmaceutical ingredients." This is because there is a time lag between the introduction of the drug into the market and its inclusion in the pharmacopoeias. Hence it becomes necessary to develop newer analytical methods for routine analysis of these drugs which will help to ensure the identity, purity, potency and performance of the drugs in the dosage forms.
Author: Joachim Ermer Publisher: John Wiley & Sons ISBN: 3527672184 Category : Medical Languages : en Pages : 451
Book Description
This second edition of a global bestseller has been completely redesigned and extensively rewritten to take into account the new Quality by Design (QbD) and lifecycle concepts in pharmaceutical manufacturing. As in the first edition, the fundamental requirements for analytical method validation are covered, but the second edition describes how these are applied systematically throughout the entire analytical lifecycle. QbD principles require adoption of a systematic approach to development and validation that begin with predefined objectives. For analytical methods these predefined objectives are established as an Analytical Target Profile (ATP). The book chapters are aligned with recently introduced standards and guidelines for manufacturing processes validation and follow the three stages of the analytical lifecycle: Method Design, Method Performance Qualification, and Continued Method Performance Verification. Case studies and examples from the pharmaceutical industry illustrate the concepts and guidelines presented, and the standards and regulations from the US (FDA), European (EMA) and global (ICH) regulatory authorities are considered throughout. The undisputed gold standard in the field.
Author: Christopher M. Riley Publisher: Elsevier ISBN: 0081028253 Category : Science Languages : en Pages : 696
Book Description
Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Second Edition, presents a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development, validation of analytical methods, and their application in practice. This thoroughly revised second edition covers topics not covered or not substantially covered in the first edition, including method development and validation in the clinical phase, method transfer, process analytical technology, analytical life cycle management, special challenges with generic drugs, genotoxic impurities, topical products, nasal sprays and inhalation products, and biotechnology products. The book's authors have been carefully selected as former members of the ICH Expert Working Groups charged with developing the ICH guidelines, and/or subject-matter experts in the industry, academia and in government laboratories. Presents a critical assessment of the application of ICH guidelines on method validation and specification setting Written by subject-matter experts involved in the development and application of the guidelines Provides a comprehensive treatment of the analytical methodologies used in the analysis, control and specification of new drug substances and products Covers the latest statistical approaches (including analytical quality by design) in the development of specifications, method validation and shelf-life prediction
Author: Mark Stauffer Publisher: BoD – Books on Demand ISBN: 1789230845 Category : Science Languages : en Pages : 176
Book Description
This book seeks to introduce the reader to current methodologies in analytical calibration and validation. This collection of contributed research articles and reviews addresses current developments in the calibration of analytical methods and techniques and their subsequent validation. Section 1, "Introduction," contains the Introductory Chapter, a broad overview of analytical calibration and validation, and a brief synopsis of the following chapters. Section 2 "Calibration Approaches" presents five chapters covering calibration schemes for some modern analytical methods and techniques. The last chapter in this section provides a segue into Section 3, "Validation Approaches," which contains two chapters on validation procedures and parameters. This book is a valuable source of scientific information for anyone interested in analytical calibration and validation.
Author: Bhavinkumar Vaishnani
Author: Bhavinkumar Vaishnani
Author: Michael E. Swartz
Author: Michael E. Swartz
Author: Satish Y. Gabhe
Author: Christopher M. Riley
Author: Joachim Ermer
Author: Deepali Chavan
Author: Joachim Ermer
Author: Christopher M. Riley
Author: Mark Stauffer